Journal for ImmunoTherapy of Cancer (Nov 2023)

650 Neoadjuvant ezabenlimab or pembrolizumab in combination with an anti-SIRPα antibody in resectable colorectal cancer

  • Noam Harpaz,
  • Samarth Hegde,
  • Lisa Fitzgerald,
  • Stephen Ward,
  • Miriam Merad,
  • Thomas Marron,
  • Zheng Zhu,
  • Qingqing Liu,
  • Celina Ang,
  • Deborah Doroshow,
  • Umut Sarpel,
  • Kathy Wu,
  • Ana Acuna-Villaorduna,
  • Natalie Lucas,
  • Nicholas Venturini,
  • Raphaël Mattiuz,
  • Clotilde Hennequin,
  • Jessica Le Berichel,
  • Theodore Chin,
  • Amanda Reid,
  • Leanna Troncoso,
  • David Greenwald,
  • Ari Grinspan,
  • Steve Itzkowitz,
  • Aimee L Lucas,
  • Dana Zalkin,
  • Peter Kozuch,
  • Sergey Khaitov,
  • Alex Ky-Miyasaka,
  • Randolph Steinhagen,
  • Patricia Sylla,
  • Gunther Kretschmar,
  • John Paulsen,
  • Xintong Wang,
  • Alexandros D Polydorides,
  • Deirdre Cohen,
  • Gabriela Fazilov,
  • Gary Shelton,
  • Amber Cameron,
  • Megan Yuan

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0650
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.